All Featured Insights

All organizations, including America’s hospitals and health systems, need to confront the fact that no strategic plan lasts forever.

Although lifting the Public Health Emergency (PHE) sends a hopeful message in the country’s battle against the coronavirus, phasing out this federal funding will bring new financial challenges to a battle-weary hospital industry.

While leaders are “keeping the lights on,” where will growth come from? For much of the last decade, rapid revenue growth was the predominant business imperative in the healthcare...

Those of you who read my blog regularly know that my focus tends toward either hospital operations or healthcare policy. In my latest blog, I want to change the pace and talk about the value of a well-planned and well-executed Board retreat.

Explore how hospitals and health systems are faring in an increasingly productized healthcare marketplace.

When the nation is unprepared for catastrophic public health emergencies, the consequences are as real as they can get. As we saw with COVID-19, many people died while the country’s public health apparatus struggled to catch up, and America’s hospitals, jumped into the breach.

For nearly all health systems, oncology services are an important driver of financial stability and growth. And as cancer care increasingly embraces precision medicine and personalized therapies, health systems must evolve accordingly.

As much as 80% of health outcomes are determined by circumstances and factors outside of clinical care.

Hear from our panel of experts on how to prepare and manage covenant breaches while developing a path toward financial sustainability.

Over the course of the last decade, the idea that healthcare providers need to be more consumer-centric has gradually become conventional wisdom.

One of the COVID pandemic’s most bitter lessons has been the complete inadequacy and dysfunction of the U.S. public health system, if the word “system” can even be applied.

In this webinar, Kaufman Hall Senior Vice Presidents Steven Sohn and Geoff Stenger will discuss impacts of the LIBOR transition on bank credit agreements and derivatives, including LIBOR replacement alternatives, amendment options for existing agreements, and fallback rate calculations for LIBOR-based swaps.